FTC Sues to Block Cencora’s $3.5 Billion Veterinary Unit Sale
The U.S. Federal Trade Commission sued to block Cencora’s planned $3.5 billion sale of its veterinary unit to Covetrus.
Related stories
EU Approves Novo Nordisk’s Frehemgo for Hemophilia A
Novo Nordisk said the European Commission approved Frehemgo for routine prophylaxis to prevent or reduce bleeding episodes in patients with hemophilia A.
M impact | REGULATION | Nov 13, 2026, 05:16 PM UTC
Appeals Court Rules Against Trump Administration on New York Highway Funds
L impact | REGULATION | Nov 13, 2026, 05:10 PM UTC
Novo Nordisk Wins EU Authorisation for Haemophilia A Treatment
The European Commission authorised FREHEMGO (denecimig) for routine prophylaxis in adults and children with haemophilia A, with or without inhibitors. Dosing options are monthly, e
M impact | REGULATION | Nov 13, 2026, 04:51 PM UTC
Appeals Court Says Trump Cannot Withhold Highway Funding From New York
A federal appeals court ruled that Trump cannot withhold highway funding from New York.
M impact | REGULATION | Nov 13, 2026, 04:16 PM UTC
FTC Sues to Block Covetrus’s $3.5 Billion Acquisition of MWI
The Federal Trade Commission sued to block Covetrus and its owners from acquiring rival MWI, alleging the combination would raise costs and prices for veterinary clinics and pet ow
M impact | REGULATION | Nov 13, 2026, 03:02 PM UTC
EU Panel Backs AstraZeneca’s Baxdrostat for Marketing Authorisation
AstraZeneca said a European medicines committee backed its hypertension pill, branded Baxfendy, for marketing authorisation. If authorised, it could be the first drug of its class
M impact | REGULATION | Nov 13, 2026, 02:02 PM UTC